Ironwood Pharmaceuticals Inc. Receives $50,000,000 New Financing
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d006ffba-4ecd-4ff1-a176-a4fb19bcd930&Preview=1
Date 10/2/2008
Company Name Ironwood Pharmaceuticals Inc.
Mailing Address 320 Bent Street Cambridge, MA 02141
Company Description We are committed to the development of successful human medicines. Drugmaking is not a statistical event, nor simply a high-throughput industrialized pursuit. Our team is forging a process for creating and developing novel drug candidates that integrates the most successful drugmaking practices of the past and the best of today’s cutting-edge technologies. Our efficient discovery and development processes, focused on important human needs, are generating a robust pipeline.
Proceeds Purposes This infusion of equity capital will enable us to execute on our comprehensive development plans for linaclotide, which has the potential to benefit millions of patients; advance our pipeline of therapeutic candidates; and grow our sales and marketing team to commercialize our products.